NO20024623L - Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform - Google Patents
Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallformInfo
- Publication number
- NO20024623L NO20024623L NO20024623A NO20024623A NO20024623L NO 20024623 L NO20024623 L NO 20024623L NO 20024623 A NO20024623 A NO 20024623A NO 20024623 A NO20024623 A NO 20024623A NO 20024623 L NO20024623 L NO 20024623L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- crystal form
- novel process
- new crystal
- imidazopyridine derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000092565 | 2000-03-30 | ||
| PCT/JP2001/002620 WO2001074821A1 (fr) | 2000-03-30 | 2001-03-29 | Nouveau procede de production de derive d'imidazopyridine fondu et nouvelle forme cristalline |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024623D0 NO20024623D0 (no) | 2002-09-26 |
| NO20024623L true NO20024623L (no) | 2002-11-08 |
Family
ID=18607880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024623A NO20024623L (no) | 2000-03-30 | 2002-09-26 | Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7049437B2 (no) |
| EP (1) | EP1270578A4 (no) |
| JP (1) | JP3481930B2 (no) |
| KR (1) | KR20020082898A (no) |
| CN (1) | CN1203073C (no) |
| AU (1) | AU2001244613A1 (no) |
| BR (1) | BR0109643A (no) |
| CA (1) | CA2403131A1 (no) |
| CZ (1) | CZ20023276A3 (no) |
| HK (1) | HK1054387A1 (no) |
| HU (1) | HUP0300580A3 (no) |
| IL (1) | IL151877A0 (no) |
| MX (1) | MXPA02009460A (no) |
| NO (1) | NO20024623L (no) |
| PL (1) | PL357672A1 (no) |
| WO (1) | WO2001074821A1 (no) |
| ZA (1) | ZA200207295B (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1250550C (zh) | 2001-07-16 | 2006-04-12 | 盐野义制药株式会社 | 脒衍生物的制备方法 |
| JPWO2004078173A1 (ja) * | 2003-02-05 | 2006-06-08 | 塩野義製薬株式会社 | 溶出性の改善された錠剤 |
| EP1653914A4 (en) | 2003-08-12 | 2008-10-29 | 3M Innovative Properties Co | COMPOUNDS CONTAINING OXIME SUBSTITUTED IMIDAZO STRUCTURE |
| NZ545412A (en) | 2003-08-27 | 2008-12-24 | Coley Pharm Group Inc | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| CA2537763A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for cd5+ b cell lymphoma |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| BRPI0414856A (pt) | 2003-10-03 | 2006-11-21 | 3M Innovative Properties Co | imidazoquinolinas alcóxi-substituìdas |
| CN1906193A (zh) | 2003-11-14 | 2007-01-31 | 3M创新有限公司 | 肟取代的咪唑环化合物 |
| CA2545825A1 (en) * | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
| MXPA06005910A (es) | 2003-11-25 | 2006-08-23 | 3M Innovative Properties Co | Sistemas de anillo imidazo sustituido y metodos. |
| WO2005066170A1 (en) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| JP2007517044A (ja) | 2003-12-30 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド |
| AU2005228150A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| WO2005094770A1 (en) * | 2004-03-30 | 2005-10-13 | Unilever Plc | Skin lightening compositions comprising vitamines and flavonoids |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| WO2006009832A1 (en) * | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Substituted imidazo ring systems and methods |
| WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| JP5313502B2 (ja) | 2004-12-30 | 2013-10-09 | スリーエム イノベイティブ プロパティズ カンパニー | 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| EP1831226B1 (en) | 2004-12-30 | 2012-08-08 | 3M Innovative Properties Company | Chiral tetracyclic compounds inducing interferon biosynthesis |
| US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
| CA2597587A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
| JP2008538550A (ja) | 2005-04-01 | 2008-10-30 | コーリー ファーマシューティカル グループ，インコーポレイテッド | ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物 |
| AU2006232377A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
| CA2623541A1 (en) * | 2005-09-23 | 2007-03-29 | Coley Pharmaceutical Group, Inc. | Method for 1h-imidazo[4,5-c]pyridines and analogs thereof |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| ES2966512T3 (es) | 2019-04-12 | 2024-04-22 | Blueprint Medicines Corp | Formas cristalinas de (S)-1-(4-fluorofenil)-1-(2-(4-(6-(1-metil-1H-pirazol-4-il)pirrolo[2,1-f][1,2,4]triazin-4-il)piperazinil)-pirimidin-5-il)etan-1-amina y métodos de elaboración |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378848A (en) * | 1992-02-12 | 1995-01-03 | Shionogi & Co., Ltd. | Condensed imidazopyridine derivatives |
| IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
-
2001
- 2001-03-29 AU AU2001244613A patent/AU2001244613A1/en not_active Abandoned
- 2001-03-29 BR BR0109643-5A patent/BR0109643A/pt not_active IP Right Cessation
- 2001-03-29 MX MXPA02009460A patent/MXPA02009460A/es not_active Application Discontinuation
- 2001-03-29 CN CNB018073417A patent/CN1203073C/zh not_active Expired - Fee Related
- 2001-03-29 CZ CZ20023276A patent/CZ20023276A3/cs unknown
- 2001-03-29 KR KR1020027012412A patent/KR20020082898A/ko not_active Application Discontinuation
- 2001-03-29 PL PL01357672A patent/PL357672A1/xx not_active Application Discontinuation
- 2001-03-29 HU HU0300580A patent/HUP0300580A3/hu unknown
- 2001-03-29 IL IL15187701A patent/IL151877A0/xx unknown
- 2001-03-29 CA CA002403131A patent/CA2403131A1/en not_active Abandoned
- 2001-03-29 US US10/239,785 patent/US7049437B2/en not_active Expired - Fee Related
- 2001-03-29 EP EP01917588A patent/EP1270578A4/en not_active Withdrawn
- 2001-03-29 WO PCT/JP2001/002620 patent/WO2001074821A1/ja not_active Application Discontinuation
- 2001-03-29 JP JP2001572511A patent/JP3481930B2/ja not_active Expired - Fee Related
-
2002
- 2002-09-11 ZA ZA200207295A patent/ZA200207295B/en unknown
- 2002-09-26 NO NO20024623A patent/NO20024623L/no not_active Application Discontinuation
-
2003
- 2003-09-16 HK HK03106654.1A patent/HK1054387A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3481930B2 (ja) | 2003-12-22 |
| EP1270578A1 (en) | 2003-01-02 |
| AU2001244613A1 (en) | 2001-10-15 |
| WO2001074821A1 (fr) | 2001-10-11 |
| IL151877A0 (en) | 2003-04-10 |
| CZ20023276A3 (cs) | 2003-02-12 |
| NO20024623D0 (no) | 2002-09-26 |
| CA2403131A1 (en) | 2001-10-11 |
| US7049437B2 (en) | 2006-05-23 |
| KR20020082898A (ko) | 2002-10-31 |
| HUP0300580A2 (hu) | 2003-07-28 |
| CN1419557A (zh) | 2003-05-21 |
| EP1270578A4 (en) | 2004-11-03 |
| MXPA02009460A (es) | 2003-02-12 |
| US20030088102A1 (en) | 2003-05-08 |
| ZA200207295B (en) | 2003-09-11 |
| HUP0300580A3 (en) | 2006-06-28 |
| BR0109643A (pt) | 2003-04-22 |
| CN1203073C (zh) | 2005-05-25 |
| HK1054387A1 (zh) | 2003-11-28 |
| PL357672A1 (en) | 2004-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024623L (no) | Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform | |
| NO20030844D0 (no) | Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav | |
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| NO20031694L (no) | Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament | |
| NO20022176D0 (no) | Absorberende gjenstand og fremgangsmåte for fremstilling av denne | |
| NO20032518D0 (no) | Fremgangsmåte for fremstilling av amlodipinmaleat | |
| CY2009001I1 (el) | Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης | |
| NO20015542L (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| NO20013942L (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20023950D0 (no) | Fremgangsmåte for fremstilling av en titanholdig zeolitt | |
| NO20024321D0 (no) | Fremgangsmåte for fremstilling av krystallinsk form I av kabergolin | |
| NO20021124D0 (no) | Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor | |
| NO20031413L (no) | Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt | |
| NO20003555L (no) | Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer | |
| NO20025069D0 (no) | Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme | |
| NO20025423L (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20023973D0 (no) | Fremgangsmåte for fremstilling av en titanholdig zeolitt | |
| DK1339723T3 (da) | Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner | |
| NO20021118D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
| NO20030515L (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| NO20023577L (no) | Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider | |
| NO20030587D0 (no) | Fremgangsmåte til fremstilling av diskodermolid og analoger derav | |
| NO20032297D0 (no) | Fremgangsmåte for fremstilling av distamycinderivater | |
| NO20023702D0 (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder | |
| NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |